PXL/HO/Cir-009/2021-22 Date: 03.05.2021
Subject: Invitations for Applications under Production Linked Incentive (PLI) Scheme for promotion of Domestic Manufacturing of critical KSMs/DI/API in India for leftover slots/quantities of eligible products.
Members are kindly aware that the Department of Pharmaceuticals (DoP) had rolled out Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of KSMs, Drug Intermediates and Active Pharmaceutical Ingredients in India and issued guidelines on 29th Oct 2020.The applications received till 30th Nov 2020 were appraised by the DoP and the selected applicants are informed.
Now the Department of Pharma is inviting applications from eligible applicants under the scheme for leftover slots/quantities of the eligible products i.e The APIs under Segment-II include neomycin, gentamycin, clindamycin base, tetracycline, streptomycin, vitamin B1, chemical synthesis based KSMs or drug intermediates under segment-III- dicyandiamide (DCDA) and other KSMs, DIs and APIs under Segment-IV- norfloxacin, Artesunate, Aspirin and vitamin B6.
The complete details of eligible products, guidelines may please be find and the eligible applicants my apply online. Kindly note that the last date for applications is July 28, 2021.